NIAID animation explains the ever-changing nature of influenza viruses.
Learn how immunizing a critical portion of a community protects most members of the community.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Media Availability: HVTN 505 Vaccine Induced Antibodies Nonspecific for HIV—July 30, 2015
Media Availability: Experimental MERS Vaccine Shows Promise in Animal Studies—July 28, 2015
Media Availability: Two Paths Pave Way for Development of a Preventive HIV Vaccine—July 23, 2015
Ebola Vaccine Trial Opens in Liberia—Feb. 2, 2015
Read More: All Vaccine News Releases | News From NIAID-Supported Institutions
Program Announcement: Information about Grants for Research to Advance Vaccine Safety (R01 and R21)
Overcoming Challenges in Staphylococcus aureus Vaccine Development - Meeting Summary, June 7, 2013 (PDF)
Jordan Report: Accelerated Development of Vaccines 2012
Last Updated July 30, 2015